Sign up to save your podcasts
Or
Share Episode 8 John Leonard CEO of Intellia Therapeutics
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode 8 John Leonard CEO of Intellia Therapeutics
A Between the Biotech Waves conversation with John Leonard, CEO of Intellia Therapeutics. John has over 30 years of experience in drug research & development. Prior to joining Intellia John was CSO at Abbvie. In this episode we discuss the formation of Intellia, some of the challenges and the recent data announced in ATTR.
View all episodes
By Nessan Bermingham PhD
4.9
2121 ratings
A Between the Biotech Waves conversation with John Leonard, CEO of Intellia Therapeutics. John has over 30 years of experience in drug research & development. Prior to joining Intellia John was CSO at Abbvie. In this episode we discuss the formation of Intellia, some of the challenges and the recent data announced in ATTR.
More shows like Between the Biotech Waves
View all
WSJ What’s News
4,326 Listeners
WSJ Your Money Briefing
1,715 Listeners
Marketplace
8,637 Listeners
Acquired
4,221 Listeners
Odd Lots
1,865 Listeners
Animal Spirits Podcast
1,999 Listeners
The Indicator from Planet Money
9,508 Listeners
The Readout Loud
316 Listeners
The Long View
885 Listeners
Business Of Biotech
86 Listeners
BioCentury This Week
30 Listeners
Raising Health
144 Listeners
Biotech Hangout
18 Listeners
Ground Truths
49 Listeners
Money Stuff: The Podcast
377 Listeners